ACRV

Acrivon Therapeutics, Inc. is a forward-looking biopharmaceutical company located in Watertown, Massachusetts, dedicated to pioneering precision oncology therapies that significantly enhance patient outcomes in cancer care. Utilizing its innovative proprietary platform, Acrivon is committed to developing personalized medicines aligned with specific genetic tumor profiles, which meets the increasing demand for targeted cancer treatments. With a strong emphasis on research and a promising pipeline, Acrivon offers an enticing investment prospect for institutional investors seeking to contribute to the evolution of advanced cancer therapies and personalized medicine.